So the Thymus produces T cells. IL-15 is a T cell growth factor.
When the Thymus is removed, there is a 2x higher chance of dying earlier of all causes according to this report. These findings are consistent with the JAMA paper that shows when ALC is less than 1,500 (low T cells) longevity is decreased with increased mortality risk from all causes.
The data is consistent:
IL-15 is a T cell growth factor and they called T cells because of the T in Thymus. And IL-15 was ranked #1 by NCI and FDA to "cure" cancer as far back as 2007.
Now this report links the Thymus (which produces T cells) to longevity - consistent with the JAMA report that 52 million Americans suffer from low T cells, called lymphopenia.
IL-15 to treat cancer, enable longevity and to overcome sepsis - Immunotherapy 2.0. Stay tuned.
Are the dots connecting that ALC matters?
JAMA Zidar 2019: "Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population"
https://t.co/P8RVsZYhIi
WaPo Gift Link: "The body's most mysterious organ may play a key role in longevity and cancer. What to know about the incredible shrinking thymus"
Dr. Patrick Soon-Shiong drops a paradigm-shifting take on cancer treatment in this clip: For 50 years, we've fought cancer like a war—using poisons (chemo) and radiation to shrink tumors temporarily—while unknowingly wiping out the very immune cells that could remember the enemy and deliver long-term survival.
He compares it to the gastric ulcer breakthrough: Doctors ridiculed the idea that an ulcer was caused by infection (treatable with antibiotics) until the science proved it right. Same story here?
Core insight: The root cause of cancer (and even limited longevity) is immune system collapse. Maintain robust protective cells → you don't just survive cancer, you thrive into old age. He cites the world's oldest person (lived to 122) whose only standout feature was an exceptionally active immune system.
It's a call to rethink: Stop treating symptoms with war-era weapons; focus on restoring and protecting the immune system as the real battlefield.
Mind-blowing or overhyped? Have you seen cases where immune-focused approaches changed outcomes—or are we still too locked into the old paradigm? Share your thoughts below.
Suudi Arabistan Gıda ve İlaç İdaresi, Mesane ve Akciğer Kanseri Tedavisi İçin Kanseri Kemoterapisiz Yok Eden 'Anktiva' Adlı Çığır Açan Yeni Kanser İlacına Hızlandırılmış Onay Verdi.
Anktiva, vücudun kendi savunma sistemini harekete geçiren yeni nesil bir immünoterapi ilacıdır. Yani kanseri doğrudan zehirlemek yerine, vücudun kanserle savaşan askerlerini güçlendirerek etki gösterir.
Bu ilaç, bağışıklık sistemimizin kanserli hücreleri tanıyıp yok edebilenen önemli savaşçıları olan NK hücrelerini ve kanseri tanıyıp hatırlayan T bağışıklık hücrelerini çoğaltıp daha aktif hâle getirir. Böylece bağışıklık sistemi, kanser hücrelerini daha kolay bulur ve hedef alır.
Klasik kemoterapiler çoğu zaman sağlıklı hücrelere de zarar verir ve bağışıklığı zayıflatır. Anktiva ise tam tersine, bağışıklık sistemini güçlendirmeyi amaçlar. Bu nedenle daha hedefli etki, daha az yan etkive daha uzun süreli bir bağışıklık cevabı sunma potansiyeline sahiptir.
Bu yaklaşımın ne kadar güçlü olabileceğini gösteren çarpıcı bir örnek de klinik çalışmalarda rapor edilmiştir: Kemik iliğinin %95’i kanser hücreleriyle dolmuş, standart tedavilere hiç cevap vermeyen bir lenfoma (kan kanseri) hastasında, hastadan ya da uygun bir bağışçıdan alınan bağışıklık hücreleri laboratuvar ortamında kanseri tanıyıp saldıracak şekilde güçlendirilmiş ve tekrar hastaya verilmiştir. Sonuçta kemik iliği tamamen temizlenmiş ve hastada 15 aydır hastalığa dair hiçbir bulguya rastlanmamıştır. Bu örnek, bağışıklık sistemini doğru şekilde yönlendirmenin kanserle mücadelede ne kadar etkili olabileceğini göstermektedir.
Yapılan klinik çalışmalarda, özellikle standart tedavilere cevap vermeyen zor vakalarda, bağışıklık sisteminin yeniden toparlandığı, hastaların hayat süresinin uzadığı ve başta akciğer kanseri olmak üzere farklı kanser türlerinde umut verici sonuçlar elde edildiği bildirilmektedir.
Anktiva’nın geliştirildiği şirketin kurucusu, dünyaca tanınmış milyarder cerrah ve bilim adamı Dr. Patrick Soon-Shiong’dur. Şirket, kemoterapisiz bağışıklık temelli tedaviler üzerinde uzun süredir çalışmalar yürütmektedir.
Suudi Arabistan’ın, Anktiva’yı yetişkin mesane ve akciğer kanseri hastaları için onaylaması, bağışıklık sistemi temelli kanser tedavilerinde önemli ve öncü bir adım olarak görülmektedir.
Bu onay, tedavi için ülkeye hasta akını başlatması ihtimalini de güçlendirmiştir.
RFK Jr: "The polio vaccine contained a virus called SV40."
"It's one of the most carcinogenic materials that is known to man."
"But it was in that vaccine. 98 million people... in my generation got it."
"And now you've had this explosion of soft tissue cancers in our generation that kill many, many, many, many, many more people than polio ever did."
How TF is this not a War Crime?
“We found that vaccinated children had 54% HIGHER CANCER RATES compared to the unvaccinated in our peer-reviewed reanalysis of the Henry Ford birth-cohort study...
Working to explain to the world how and why Bioshield works.
T cells and NK cells kill cancer, that’s irrefutable.
Low NK cells and T cells means cancer grows, that’s irrefutable.
So if there is a drug available to boost NK and T cells then there is better chance to kill the cancer cell of any tumor type – That’s the how and it is that simple.
1. NK and T cells (lymphocytes) kill cancer… causation
2. Anktiva proliferates, grows and activates NK and T cells in the body... causation (and in the FDA approved label)
3. Adding Anktiva to current standards of care have shown prolonged survival in patients with cancer across multiple tumor types since it is treating the immune system... causation.
That is the HOW!
Anktiva the Bioshield is the first immunotherapy in history of medicine that is FDA approved with a mechanism of action to grow and supercharge NK and T cells in the body, generate memory T cells and restore the immune system without stimulating immunosuppressive T cells.
Now what's next? We can measure low NK and T cells (lymphopenia) with a simple blood test (ALC). This is no different than the same test measuring low red blood cells (anemia) or low neutrophils (neutropenia). Low NK and T cells are called lymphopenia. Ask your doctor what is my ALC? (absolute lymphocyte count)
Today, FDA has approved EPOGEN to treat anemia regardless of cancer type and has approved NEUPOGEN to treat neutropenia regardless of cancer type. So, based on the mechanism of action of ANKTIVA and the irrefutable causation that NK cells and T cells kill cancer, ANKTIVA should be enabled to treat patients with low NK and T cells (lymphopenia) regardless of tumor type. Especially since ANKTIVA, by activating NK and T cells (reversing lymphopenia) is the only FDA APPROVED mechanism of action in the label to generate MEMORY T CELLS. This supercharging of the immune system happens regardless of the cancer type and we have now shown in completed clinical trials across multiple tumor types including lung cancer (NSCLC), small-cell lung cancer (SCLC), urothelial carcinoma, head and neck cancer, melanoma, colorectal cancer, cervical cancer, renal cell carcinoma, gastric cancer, and hepatocellular carcinoma (manuscript in progress) that by increasing NK and T cells, we induce prolonged survival in patients who have failed all standards of care including current immunotherapy with checkpoint inhibitors. This mechanism of action has already been approved showing long term complete responses, but approved only for an orphan state of a subset of bladder cancer.
So, if ANKTIVA could receive the same consideration as EPOGEN and NEUPOGEN as an immune supportive agent, many patients could benefit now without having to fly to LA. I hope we can change that quickly and change the lives of countless of desperate patients in which all standards of care have failed. Working hard to change the course of cancer everyday.
The paradigm change is we are treating the immune system, regardless of its cancer type. Cancer is the symptom and the collapse of the immune system is the root cause.
Summary (4:45pm, 22 Feb 2025)
Autism = 1 in 31 (1 in 12 for boys) - Hyperpandemic
Multifactorial Causes:
A. Vaccines
B. Acetaminophen supra-additive interaction
C. Folate deficiency
FDA will notify physicians that
1. vaccine schedules are too aggressive / excessive / bundled
2. the use of acetaminophen should be eliminated as a treatment for vaccine reactions
3. the use of acetaminophen should be eliminated during pregnancy
4. An end to silencing and demonizing mothers (parents) who cite vaccine injury
5. "We will perform the studies which should have been done 25 years ago."
TRUMP: “We have already taken out and are in the process of taking out mercury and aluminum … You know what aluminum is? Who the hell wants that pumped into a body? … We're having them taken out of the vaccines.”
Some 40-70% of mothers who have children with autism believe that their child was injured by a vaccine. President Trump believes that we should be listening to these mothers instead of gaslighting and marginalizing them like prior administrations.
We documented the first-ever direct evidence that mRNA “vaccine” genetic code integrates into the human genome.
In a young stage IV bladder cancer patient, chromosome 19 now carries a Spike-encoding gene sequence.
PERFECT 20/20 bp match — 1 in a TRILLION chance of coincidence.
If you believe free speech is for you but not your political opponents, you're illiberal.
If no contrary evidence could change your beliefs, you're a fundamentalist.
If you believe the state should punish those with contrary views, you're a totalitarian.
If you believe political opponents should be punished with violence or death, you're a terrorist.